Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Type I diabetes mellitus | R-HSA-5683209 | map04940 | fusaric acid | 2771 | drug-path |
Basal cell carcinoma | R-HSA-5626181 | map05217 | fusaric acid | 2771 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | boldine | 265237 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | boldine | 265237 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | boldine | 265237 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | boldine | 265237 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | boldine | 265237 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | boldine | 265237 | drug-path |
Asthma | R-HSA-444620 | map05310 | boldine | 265237 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | boldine | 265237 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | boldine | 265237 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | boldine | 265237 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | boldine | 265237 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | boldine | 265237 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | yohimbic acid | 72131 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | yohimbic acid | 72131 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | yohimbic acid | 72131 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | yohimbic acid | 72131 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | calcium pantothenate | 5324346 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | calcium pantothenate | 5324346 | drug-path |